Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Methods in Enzymology|January 16, 2014
Pulse-chase analysis to measure protein degradationEinav Simon, Daniel KornitzerJournal of Molecular Biology|June 15, 2013
Phosphorylation of the cyclin CaPcl5 modulates both cyclin stability and specific recognition of the substrateEinav Simon, Tsvia Gildor, Daniel KornitzerPathology International|January 16, 2014
KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literatureDov Hershkovitz, Euvgeni Vlodavsky, Einav Simon, et al.Molecular and Cellular Biology|September 17, 2008
Autophosphorylation-induced degradation of the Pho85 cyclin Pcl5 is essential for response to amino acid limitationSharon Aviram, Einav Simon, Tsvia Gildor, et al.Experimental and Molecular Pathology|January 15, 2013
Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylationYehudit Peerless, Einav Simon, Edmond Sabo, et al.Plos One|March 14, 2017
Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapyEyal Asor, Michael Y Stav, Einav Simon, et al.The Journal of Clinical Endocrinology and Metabolism|February 3, 2016
Subclonality for BRAF Mutation in Papillary Thyroid Carcinoma Is Associated With Earlier Disease StageAlona Finkel, Lior Liba, Einav Simon, et al.Human Pathology|July 8, 2014
Adenoma and carcinoma components in colonic tumors show discordance for KRAS mutationDov Hershkovitz, Einav Simon, Tova Bick, et al.Pancreas|December 10, 2015
Intratumor Heterogeneity of KRAS Mutation Status in Pancreatic Ductal Adenocarcinoma Is Associated With Smaller LesionsSima S Nagawkar, Samah Abu-Funni, Einav Simon, et al.Oncotarget|May 15, 2017
Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomasEinav Simon, Tova Bick, Shada Sarji, et al.Pageof 3